Companies with a Future performance score of at least 3, ordered by Future performance score.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
KEBNI B	SEK 1.30	15.5%	-31.4%	SEK 367.8m	SEK 1.60	3.1	82.7%	n/a	Tech
ENRAD	SEK 9.84	0.2%	-5.8%	SEK 256.6m	SEK 11.40	5.7	61.9%	n/a	Capital Goods
CAMX	SEK 533.00	-1.7%	-9.3%	SEK 31.7b	SEK 771.38	46.5	34.9%	n/a	Pharmaceuticals & Biotech
HACK	SEK 73.70	-5.0%	n/a	SEK 21.3b	SEK 103.49	12.6	24.8%	5.9%	Media
CLAV	SEK 4.77	16.4%	-1.7%	SEK 1.7b	n/a	503.0	73.9%	n/a	Software
MIPS	SEK 241.00	0.6%	-47.4%	SEK 6.4b	SEK 492.00	49.1	42.1%	1.0%	Consumer Durables
SKOLON	SEK 22.00	1.9%	-31.7%	SEK 584.0m	SEK 32.50	2.8	80.4%	0%	Software
CTT	SEK 132.80	-0.9%	-36.2%	SEK 1.7b	n/a	40.0	47.1%	1.8%	Capital Goods
EQL	SEK 25.20	6.1%	-72.0%	SEK 744.1m	SEK 50.00	59.4	67.3%	n/a	Healthcare
BONEX	SEK 208.20	-9.8%	-22.8%	SEK 13.7b	SEK 373.83	74.1	33.8%	n/a	Pharmaceuticals & Biotech
BIOA B	SEK 295.40	5.0%	53.4%	SEK 26.2b	SEK 301.40	122.9	53.3%	0.7%	Pharmaceuticals & Biotech
PLEJD	SEK 668.00	1.2%	n/a	SEK 7.5b	SEK 610.00	58.8	28.3%	n/a	Capital Goods
ARFA	SEK 68.50	1.6%	n/a	SEK 600.0m	SEK 120.00	18.0	22.8%	0%	Commercial Services
WAYS	SEK 41.40	1.2%	7.0%	SEK 363.0m	SEK 59.00	59.6	53.2%	0%	Tech
SHOT	SEK 89.50	4.6%	13.2%	SEK 19.3b	SEK 93.86	29.9	34.1%	2.9%	Consumer Services
ACE	SEK 3.03	4.8%	-28.4%	SEK 369.9m	SEK 5.60	4.9	104.9%	n/a	Pharmaceuticals & Biotech
GAPW B	SEK 17.10	10.0%	27.0%	SEK 621.4m	SEK 20.00	7.0	64.2%	n/a	Tech
INIT	SEK 2.87	5.9%	-27.7%	SEK 196.5m	SEK 8.03	7.5	35.5%	n/a	Pharmaceuticals & Biotech
SECT B	SEK 284.00	-9.0%	-10.3%	SEK 54.7b	SEK 336.67	97.1	23.7%	0.8%	Healthcare
MTRS	SEK 188.55	-2.8%	45.7%	SEK 34.4b	SEK 225.25	71.6	44.0%	0.8%	Capital Goods
PCELL	SEK 23.82	1.1%	-2.8%	SEK 1.4b	SEK 32.00	3.9	90.9%	n/a	Capital Goods
SBB B	SEK 3.11	1.4%	-51.7%	SEK 6.0b	SEK 3.35	2.9	96.8%	0%	Real Estate Management and Development
SYNT	SEK 27.70	0%	-13.4%	SEK 1.2b	SEK 30.00	115.3	47.4%	0%	Healthcare
KONT	SEK 2.09	-9.1%	-18.4%	SEK 73.7m	SEK 4.50	1.9	134.9%	n/a	Healthcare

High Growth Potential Companies